BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27651496)

  • 1. Patients' perceptions and views of surgery and radioiodine ablation in the definitive management of Graves' disease.
    Hookham J; Truran P; Allahabadia A; Balasubramanian SP
    Postgrad Med J; 2017 May; 93(1099):266-270. PubMed ID: 27651496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery versus radioiodine therapy as definitive management for graves' disease: the role of patient preference.
    Grodski S; Stalberg P; Robinson BG; Delbridge LW
    Thyroid; 2007 Feb; 17(2):157-60. PubMed ID: 17316118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in the use of definitive treatment options in the management of Graves' disease: a UK clinician survey.
    Hookham J; Collins EE; Allahabadia A; Balasubramanian SP
    Postgrad Med J; 2017 Apr; 93(1098):198-204. PubMed ID: 27531964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine treatment of recurrent hyperthyroidism in patients previously treated for Graves' disease by subtotal thyroidectomy.
    Vestergaard H; Laurberg P
    J Intern Med; 1992 Jan; 231(1):13-7. PubMed ID: 1732393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioiodine therapy of recurrent hyperthyroidism in patients previously treated for diffuse toxic goiter with subtotal surgery].
    Vestergaard H; Laurberg P
    Ugeskr Laeger; 1993 Aug; 155(31):2403-5. PubMed ID: 8346592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and decision regret in patients with late-hypothyroidism after radioiodine treatment for Graves' disease.
    Li Y; Yang T; Ju L; Feng Y; Chen Z; Xiang X; Zhu T; Pang H; Wang Z
    Clin Endocrinol (Oxf); 2024 Jan; 100(1):87-95. PubMed ID: 37964632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
    Elston MS; Tu'akoi K; Meyer-Rochow GY; Tamatea JA; Conaglen JV
    Aust N Z J Obstet Gynaecol; 2014 Aug; 54(4):317-21. PubMed ID: 24576228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China.
    Tominaga T; Yokoyama N; Nagataki S; Cho BY; Koh CS; Chen JL; Shi Y
    Thyroid; 1997 Apr; 7(2):217-20. PubMed ID: 9133688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism.
    Gómez JM; Gómez N; Amat M; Biondo S; Rafecas A; Jaurrieta E; Soler J
    Ann Endocrinol (Paris); 2000 Sep; 61(3):184-91. PubMed ID: 10970941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
    Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of graves' ophthalmopathy.
    Moleti M; Mattina F; Salamone I; Violi MA; Nucera C; Baldari S; Lo Schiavo MG; Regalbuto C; Trimarchi F; Vermiglio F
    Thyroid; 2003 Jul; 13(7):653-8. PubMed ID: 12964971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The surgical treatment of Graves' disease].
    de Ruijter SH; van Dalen T; Muller AF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of thyroidectomy for Graves' disease: A meta-analysis.
    Palit TK; Miller CC; Miltenburg DM
    J Surg Res; 2000 May; 90(2):161-5. PubMed ID: 10792958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.